tiprankstipranks
Trending News
More News >
Elanco Animal Health (ELAN)
NYSE:ELAN
US Market
Advertisement

Elanco Animal Health (ELAN) Stock Forecast & Price Target

Compare
396 Followers
See the Price Targets and Ratings of:

ELAN Analyst Ratings

Moderate Buy
9Ratings
Moderate Buy
6 Buy
3 Hold
0 Sell
Based on 9 analysts giving stock ratings to
Elanco
Animal Health
in the past 3 months
TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers​ in the past 3 months

ELAN Stock 12 Month Forecast

Average Price Target

$18.00
▼(-2.65% Downside)
Based on 9 Wall Street analysts offering 12 month price targets for Elanco Animal Health in the last 3 months. The average price target is $18.00 with a high forecast of $21.00 and a low forecast of $15.00. The average price target represents a -2.65% change from the last price of $18.49.
{"navigator":{"disabled":true},"exporting":{"enabled":false},"title":{"text":null},"chart":{"height":200,"style":{"fontFamily":"Roboto Flex, -apple-system, BlinkMacSystemFont, Segoe UI, Roboto, Helvetica, Arial, sans-serif, Apple Color Emoji, Segoe UI Emoji, Segoe UI Symbol","fontWeight":"400","color":"#5d5d5e"},"spacingTop":30,"spacingRight":60,"events":null},"yAxis":{"labels":{"style":{"color":"inherit"},"distance":6,"x":-6,"y":-6,"zIndex":1,"map_label_formatter":{"8":"$8","15":"$15","22":"$22","11.5":"$11.5","18.5":"$18.5"}},"plotLines":[{"color":"rgba(0,0,0,0)","value":21,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":-10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-bottom flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#199ca5\">High </span>\n\n  <span style=\"color:#199ca5\">$21.00</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":18,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":0,"text":"<div  class=\"positionrelative hoverZ3 triangleleft flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#828080\">Average </span>\n\n  <span style=\"color:#828080\">$18.00</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":15,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-top flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#912767\">Low </span>\n\n  <span style=\"color:#912767\">$15.00</span>\n  </div></div>","useHTML":true}}],"tickPositions":[8,11.5,15,18.5,22],"lineColor":"#dddddd","gridLineWidth":1,"gridLineColor":"#dddddd","lineWidth":1,"title":{"text":""}},"plotOptions":{"series":{"states":{"inactive":{"opacity":1}}},"line":{"animation":{"duration":0},"dataLabels":{"allowOverlap":true},"borderWidth":1,"marker":{"enabled":true,"fillColor":"#FFFFFF","radius":3,"lineWidth":2,"symbol":"circle","lineColor":"#828080"}}},"xAxis":{"labels":{"style":{"color":"inherit"},"rotation":0,"map_label_formatter":{"3":"Nov<br/>2024","6":"Feb<br/>2025","9":"May<br/>2025","12":"Aug<br/>2025","25":"Aug<br/>2026"}},"tickPositions":[3,6,9,12,25],"plotLines":[{"color":"#dddddd","width":1,"value":12},{"color":"#dddddd","width":1,"value":12}],"lineWidth":0,"gridLineWidth":1,"gridLineColor":"#dddddd","tickLength":0},"legend":{"symbolRadius":0,"symbolPadding":4,"symbolHeight":14,"borderWidth":0,"symbolWidth":14,"align":"left","verticalAlign":"bottom","enabled":false},"tooltip":{"backgroundColor":"rgba(0,0,0,0)","useHTML":true,"borderWidth":0,"borderColor":"rgba(0,0,0,0)","padding":0,"shadow":null,"headerFormat":"","footerFormat":"","pointFormat":"<div class=\"flexccc lineHeight2 bgwhite shadow2 px3 py3 radiismall fonth10_semibold\">\n                <span class=\"colorgray-3 mb4\">{point.date:%b %d ,%Y}</span>\n                <span>Analyst Consensus</span>\n                {point.info}\n          </div>\n           </div>"},"credits":{"enabled":false},"accessibility":{"description":""},"responsive":{"rules":[{"chartOptions":{"chart":{"spacing":[0,0,0,0],"margin":[30,60,40,5]},"xAxis":{"tickPositions":[3,12,25.25]},"yAxis":{"labels":{"enabled":false}},"title":{"text":null},"subtitle":{"text":null}},"condition":{"maxWidth":500}}]},"series":[{"lineWidth":2,"dashStyle":"ShortDash","name":"High","type":"line","color":"#199ca5","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,13.79,14.344615384615384,14.899230769230769,15.453846153846154,16.00846153846154,16.563076923076924,17.11769230769231,17.67230769230769,18.22692307692308,18.78153846153846,19.33615384615385,19.89076923076923,20.445384615384615,{"y":21,"marker":{"fillColor":"#199ca5","lineColor":"#199ca5","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Average","type":"line","color":"#828080","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,13.79,14.113846153846152,14.437692307692307,14.76153846153846,15.085384615384616,15.409230769230769,15.733076923076922,16.056923076923077,16.380769230769232,16.704615384615384,17.02846153846154,17.35230769230769,17.676153846153845,{"y":18,"marker":{"fillColor":"#828080","lineColor":"#828080","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Low","type":"line","color":"#912767","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,13.79,13.883076923076922,13.976153846153846,14.069230769230769,14.162307692307692,14.255384615384616,14.348461538461539,14.44153846153846,14.534615384615384,14.627692307692307,14.72076923076923,14.813846153846153,14.906923076923077,{"y":15,"marker":{"fillColor":"#912767","lineColor":"#912767","enabled":true,"symbol":"circle"}}]},{"type":"line","data":[{"y":13.04,"date":1722470400000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 10,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 2, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":15.47,"date":1725148800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 10,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 5, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":14.5,"date":1727740800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 12,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 6, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":12.6,"date":1730419200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 14,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 12, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":13.48,"date":1733011200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 11,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 15, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":12.11,"date":1735689600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 8,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 16, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":12.03,"date":1738368000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 8,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 14, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":11.17,"date":1740787200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 9,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 10, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":10.35,"date":1743465600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 10,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 12, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":9.47,"date":1746057600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 14,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 14, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":13.42,"date":1748736000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 15,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 15, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":14.43,"date":1751328000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 18,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 11, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":13.79,"date":1754006400000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 17,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 8, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"fillColor":"black","lineColor":"black","enabled":true,"symbol":"circle"}},null,null,null,null,null,null,null,null,null,null,null,null],"color":"#0666a7"}]}
Highest Price Target$21.00Average Price Target$18.00Lowest Price Target$15.00
The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.

Detailed List of Analyst Forecasts​

Detailed List of Analyst Forecasts​
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
TR | OpenAI - 4o Analyst forecast on ELAN
TR | OpenAI - 4o
TR | OpenAI - 4o
$19.5
Buy
5.46%
Upside
Upgraded
08/19/25
AI Generated ArticleAI Generated Article
Piper Sandler Analyst forecast on ELAN
Piper Sandler
Piper Sandler
$12$18
Hold
-2.65%
Downside
Reiterated
08/11/25
Piper Sandler Remains a Hold on Elanco Animal Health (ELAN)
Leerink Partners Analyst forecast on ELAN
Leerink Partners
Leerink Partners
$18$20
Buy
8.17%
Upside
Reiterated
08/11/25
Leerink Partners Keeps Their Buy Rating on Elanco Animal Health (ELAN)
UBS
$18$19
Buy
2.76%
Upside
Reiterated
08/08/25
Elanco price target raised to $19 from $18 at UBSElanco price target raised to $19 from $18 at UBS
Morgan Stanley Analyst forecast on ELAN
Morgan Stanley
Morgan Stanley
$15
Hold
-18.88%
Downside
Reiterated
08/07/25
Elanco Animal Health: Hold Rating Amid Strong Growth and Pipeline Uncertainties
Stifel Nicolaus Analyst forecast on ELAN
Stifel Nicolaus
Stifel Nicolaus
$17$18
Buy
-2.65%
Downside
Reiterated
08/07/25
Elanco Animal Health (ELAN) Gets a Buy from Stifel Nicolaus
Bank of America Securities Analyst forecast on ELAN
Bank of America Securities
Bank of America Securities
$13$21
Buy
13.57%
Upside
Reiterated
08/07/25
Elanco Animal Health (ELAN) Gets a Buy from Bank of America Securities
J.P. Morgan Analyst forecast on ELAN
J.P. Morgan
J.P. Morgan
$18
Hold
-2.65%
Downside
Reiterated
08/07/25
Analysts Offer Insights on Healthcare Companies: GoodRx Holdings (NASDAQ: GDRX) and Elanco Animal Health (NYSE: ELAN)
William Blair Analyst forecast on ELAN
William Blair
William Blair
Buy
Reiterated
08/07/25
Elanco Animal Health: Strong Performance and Growth Potential Drive Buy Rating
TD Cowen Analyst forecast on ELAN
TD Cowen
TD Cowen
$15
Buy
-18.88%
Downside
Reiterated
06/24/25
TD Cowen Sticks to Its Buy Rating for Elanco Animal Health (ELAN)
Evercore ISI Analyst forecast on ELAN
Evercore ISI
Evercore ISI
Buy
Reiterated
05/12/25
Evercore ISI Remains a Buy on Elanco Animal Health (ELAN)
Jefferies
$18
Buy
-2.65%
Downside
Reiterated
03/03/25
Elanco Animal Health: Undervalued Growth Potential with Strong Product Performance and Debt Reduction
Barclays
$20
Buy
8.17%
Upside
Reiterated
02/25/25
Barclays Remains a Buy on Elanco Animal Health (ELAN)
Argus Research Analyst forecast on ELAN
Argus Research
Argus Research
Hold
Reiterated
11/21/24
We are reiterating our Hold rating on Elanco Animal Health Inc.
Ranks
Any
Any
Analyst Rating
Any
Any
Upside/ Downside
Any
Any
Action
Any
Any
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
TR | OpenAI - 4o Analyst forecast on ELAN
TR | OpenAI - 4o
TR | OpenAI - 4o
$19.5
Buy
5.46%
Upside
Upgraded
08/19/25
AI Generated ArticleAI Generated Article
Piper Sandler Analyst forecast on ELAN
Piper Sandler
Piper Sandler
$12$18
Hold
-2.65%
Downside
Reiterated
08/11/25
Piper Sandler Remains a Hold on Elanco Animal Health (ELAN)
Leerink Partners Analyst forecast on ELAN
Leerink Partners
Leerink Partners
$18$20
Buy
8.17%
Upside
Reiterated
08/11/25
Leerink Partners Keeps Their Buy Rating on Elanco Animal Health (ELAN)
UBS
$18$19
Buy
2.76%
Upside
Reiterated
08/08/25
Elanco price target raised to $19 from $18 at UBSElanco price target raised to $19 from $18 at UBS
Morgan Stanley Analyst forecast on ELAN
Morgan Stanley
Morgan Stanley
$15
Hold
-18.88%
Downside
Reiterated
08/07/25
Elanco Animal Health: Hold Rating Amid Strong Growth and Pipeline Uncertainties
Stifel Nicolaus Analyst forecast on ELAN
Stifel Nicolaus
Stifel Nicolaus
$17$18
Buy
-2.65%
Downside
Reiterated
08/07/25
Elanco Animal Health (ELAN) Gets a Buy from Stifel Nicolaus
Bank of America Securities Analyst forecast on ELAN
Bank of America Securities
Bank of America Securities
$13$21
Buy
13.57%
Upside
Reiterated
08/07/25
Elanco Animal Health (ELAN) Gets a Buy from Bank of America Securities
J.P. Morgan Analyst forecast on ELAN
J.P. Morgan
J.P. Morgan
$18
Hold
-2.65%
Downside
Reiterated
08/07/25
Analysts Offer Insights on Healthcare Companies: GoodRx Holdings (NASDAQ: GDRX) and Elanco Animal Health (NYSE: ELAN)
William Blair Analyst forecast on ELAN
William Blair
William Blair
Buy
Reiterated
08/07/25
Elanco Animal Health: Strong Performance and Growth Potential Drive Buy Rating
TD Cowen Analyst forecast on ELAN
TD Cowen
TD Cowen
$15
Buy
-18.88%
Downside
Reiterated
06/24/25
TD Cowen Sticks to Its Buy Rating for Elanco Animal Health (ELAN)
Evercore ISI Analyst forecast on ELAN
Evercore ISI
Evercore ISI
Buy
Reiterated
05/12/25
Evercore ISI Remains a Buy on Elanco Animal Health (ELAN)
Jefferies
$18
Buy
-2.65%
Downside
Reiterated
03/03/25
Elanco Animal Health: Undervalued Growth Potential with Strong Product Performance and Debt Reduction
Barclays
$20
Buy
8.17%
Upside
Reiterated
02/25/25
Barclays Remains a Buy on Elanco Animal Health (ELAN)
Argus Research Analyst forecast on ELAN
Argus Research
Argus Research
Hold
Reiterated
11/21/24
We are reiterating our Hold rating on Elanco Animal Health Inc.
Stocks with the Highest Top Analyst Consensus in the Healthcare Sector
Find stocks in the Healthcare sector that are highly recommended by Top Performing Analysts.

Best Analysts Covering Elanco Animal Health

1 Month
xxx
Success Rate
10/16 ratings generated profit
63%
Average Return
+6.14%
reiterated a xxx
rating 22 days ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 1 Month would result in 62.50% of your transactions generating a profit, with an average return of +6.14% per trade.
3 Months
xxx
Success Rate
8/12 ratings generated profit
67%
Average Return
+14.13%
reiterated a xxx
rating 2 months ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 3 Months would result in 66.67% of your transactions generating a profit, with an average return of +14.13% per trade.
1 Year
Jonathan BlockStifel Nicolaus
Success Rate
13/16 ratings generated profit
81%
Average Return
+23.40%
reiterated a buy rating 22 days ago
Copying Jonathan Block's trades and holding each position for 1 Year would result in 81.25% of your transactions generating a profit, with an average return of +23.40% per trade.
2 Years
xxx
Success Rate
16/16 ratings generated profit
100%
Average Return
+32.81%
reiterated a xxx
rating 22 days ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 2 Years would result in 100.00% of your transactions generating a profit, with an average return of +32.81% per trade.
The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.

ELAN Analyst Recommendation Trends

Rating
Apr 25
May 25
Jun 25
Jul 25
Aug 25
Strong Buy
4
2
1
0
0
Buy
6
12
14
18
17
Hold
12
14
15
11
8
Sell
0
0
0
0
0
Strong Sell
0
0
0
0
0
total
22
28
30
29
25
In the current month, ELAN has received 17 Buy Ratings, 8 Hold Ratings, and 0 Sell Ratings. ELAN average Analyst price target in the past 3 months is 18.00.
Each month's total comprises the sum of three months' worth of ratings.

ELAN Financial Forecast

ELAN Earnings Forecast

Next quarter’s earnings estimate for ELAN is $0.13 with a range of $0.11 to $0.14. The previous quarter’s EPS was $0.26. ELAN beat its EPS estimate 75.00% of the time in the past 12 months, while its overall industry beat the EPS estimate 57.19% of the time in the same period. In the last calendar year ELAN has Outperformed its overall industry.
Next quarter’s earnings estimate for ELAN is $0.13 with a range of $0.11 to $0.14. The previous quarter’s EPS was $0.26. ELAN beat its EPS estimate 75.00% of the time in the past 12 months, while its overall industry beat the EPS estimate 57.19% of the time in the same period. In the last calendar year ELAN has Outperformed its overall industry.

ELAN Sales Forecast

Next quarter’s sales forecast for ELAN is $1.09B with a range of $1.08B to $1.10B. The previous quarter’s sales results were $1.24B. ELAN beat its sales estimates 75.00% of the time in past 12 months, while its overall industry beat sales estimates 46.91% of the time in the same period. In the last calendar year ELAN has Outperformed its overall industry.
Next quarter’s sales forecast for ELAN is $1.09B with a range of $1.08B to $1.10B. The previous quarter’s sales results were $1.24B. ELAN beat its sales estimates 75.00% of the time in past 12 months, while its overall industry beat sales estimates 46.91% of the time in the same period. In the last calendar year ELAN has Outperformed its overall industry.

ELAN Stock Forecast FAQ

What is ELAN’s average 12-month price target, according to analysts?
Based on analyst ratings, Elanco Animal Health’s 12-month average price target is 18.00.
    What is ELAN’s upside potential, based on the analysts’ average price target?
    Currently there's no upside potential for ELAN, based on the analysts’ average price target.
    Can I see which stocks the top-ranking analysts are rating?
    Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
      How can I follow the stock ratings of top Wall Street analysts?
      Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
        Is ELAN a Buy, Sell or Hold?
        Elanco Animal Health has a consensus rating of Moderate Buy which is based on 6 buy ratings, 3 hold ratings and 0 sell ratings.
          What is Elanco Animal Health’s price target?
          The average price target for Elanco Animal Health is 18.00. This is based on 9 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
          The highest analyst price target is $21.00 ,the lowest forecast is $15.00. The average price target represents -2.65% Decrease from the current price of $18.49.
            What do analysts say about Elanco Animal Health?
            Elanco Animal Health’s analyst rating consensus is a Moderate Buy. This is based on the ratings of 9 Wall Streets Analysts.
              How can I buy shares of ELAN?
              Open a brokerage account, see exclusive account opening deals on our Best Online Brokers page.
                What am I Missing?
                Make informed decisions based on Top Analysts' activity
                Know what industry insiders are buying
                Get actionable alerts from top Wall Street Analysts
                Find out before anyone else which stock is going to shoot up
                Get powerful stock screeners & detailed portfolio analysis